Hope for dravet syndrome: Long-Term safety trial of STK-001 underway

NCT ID NCT04740476

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 34 times

Summary

This study looks at the long-term safety of an experimental drug called zorevunersen (STK-001) in 60 people with Dravet syndrome, a severe form of epilepsy. Participants must have completed a previous STK-001 study. The main goal is to check for side effects, while also tracking seizure frequency and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611, United States

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Children's National Medical Center

    Washington D.C., District of Columbia, 20010, United States

  • Cook Children's Medical Center

    Fort Worth, Texas, 76104, United States

  • Florida Hospital for Children

    Orlando, Florida, 32803, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Michigan Medicine

    Ann Arbor, Michigan, 48109, United States

  • MultiCare Health System Institute for Research and Innovation

    Tacoma, Washington, 98405, United States

  • NYU Comprehensive Epilepsy Center

    New York, New York, 10016, United States

  • Nicklaus Children's Hospital

    Miami, Florida, 33155, United States

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

  • UT LeBonheur Pediatric Specialists, Inc.

    Memphis, Tennessee, 38103, United States

  • University of California San Francisco Medical Center

    San Francisco, California, 94158, United States

  • University of Iowa Children's Hospital

    Iowa City, Iowa, 52242, United States

Conditions

Explore the condition pages connected to this study.